The Manufacturers Life Insurance Company Takes Position in Encompass Health Corporation $EHC

The Manufacturers Life Insurance Company purchased a new position in shares of Encompass Health Corporation (NYSE:EHC) in the second quarter, according to its most recent filing with the SEC. The firm purchased 133,874 shares of the company’s stock, valued at approximately $13,532,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Persistent Asset Partners Ltd acquired a new stake in Encompass Health in the second quarter valued at approximately $36,000. Keating Financial Advisory Services Inc. bought a new position in shares of Encompass Health during the 2nd quarter valued at approximately $39,000. Assetmark Inc. raised its stake in Encompass Health by 89.6% in the 1st quarter. Assetmark Inc. now owns 455 shares of the company’s stock valued at $44,000 after acquiring an additional 215 shares during the period. Caitong International Asset Management Co. Ltd grew its stake in Encompass Health by 36,200.0% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock valued at $46,000 after buying an additional 362 shares in the last quarter. Finally, Aster Capital Management DIFC Ltd purchased a new position in Encompass Health during the fourth quarter valued at approximately $55,000. 97.25% of the stock is owned by institutional investors.

Insider Activity at Encompass Health

In other Encompass Health news, EVP John Patrick Darby sold 8,906 shares of the company’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $125.95, for a total value of $1,121,710.70. Following the completion of the sale, the executive vice president directly owned 75,041 shares in the company, valued at approximately $9,451,413.95. This represents a 10.61% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Mark J. Tarr sold 173,148 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the completion of the sale, the chief executive officer directly owned 267,814 shares of the company’s stock, valued at $33,602,622.58. The trade was a 39.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.80% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Barclays increased their price target on shares of Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Leerink Partners set a $152.00 price objective on shares of Encompass Health in a research report on Friday, May 22nd. UBS Group increased their price objective on Encompass Health from $150.00 to $155.00 and gave the stock a “buy” rating in a report on Friday, August 7th. TD Cowen raised their target price on shares of Encompass Health from $125.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, August 10th. Finally, Truist Financial lifted their price target on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $148.71.

Encompass Health Stock Performance

NYSE:EHC opened at $120.98 on Friday. The stock has a market capitalization of $11.93 billion, a P/E ratio of 19.70, a P/E/G ratio of 2.42 and a beta of 0.72. Encompass Health Corporation has a 12-month low of $92.77 and a 12-month high of $127.99. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.76. The stock has a 50-day moving average price of $113.20 and a 200 day moving average price of $107.18.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.48 by $0.07. The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the business posted $1.40 earnings per share. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Equities research analysts forecast that Encompass Health Corporation will post 6.08 EPS for the current fiscal year.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be given a $0.21 dividend. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. This represents a $0.84 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Thursday, October 1st. Encompass Health’s dividend payout ratio is 12.38%.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.